APA

Kołtowski Ł., Aradi D., Huczek Z., Tomaniak M., Sibbing D., Filipiak K. J., Kochman J., Balsam P. & Opolski G. (20170713). Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773). : Kardiologia polska.

Chicago

Kołtowski Łukasz, Aradi Daniel, Huczek Zenon, Tomaniak Mariusz, Sibbing Dirk, Filipiak Krzysztof J, Kochman Janusz, Balsam Paweł and Opolski Grzegorz. 20170713. Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773). : Kardiologia polska.

Harvard

Kołtowski Ł., Aradi D., Huczek Z., Tomaniak M., Sibbing D., Filipiak K. J., Kochman J., Balsam P. and Opolski G. (20170713). Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773). : Kardiologia polska.

MLA

Kołtowski Łukasz, Aradi Daniel, Huczek Zenon, Tomaniak Mariusz, Sibbing Dirk, Filipiak Krzysztof J, Kochman Janusz, Balsam Paweł and Opolski Grzegorz. Study design and rationale for Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective percutaneous coronary intervention patients (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre trial (NCT01930773). : Kardiologia polska. 20170713.